SCHEMBL625650

SCHEMBL625650

c1cn2cc(N3CCOCC3)sc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.39
PIK3R1 P27986 2/20 0.39
AR P10275 2/20 0.38
PRKDC P78527 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
ALOX12 P18054 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 2/20 0.34
LMNA P02545 2/20 0.34
NAMPT P43490 4/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324694 0.67 PIK3R1 (0.55) PIK3CAPIK3R1KDM4EPOLBGAA
SCHEMBL623944 0.67 SMN1; SMN2 (0.40) PIK3CAARSMN1; SMN2ALDH1A1POLB
SCHEMBL2453709 0.66 PIK3R1 (0.50) PIK3CAPIK3R1
SCHEMBL14656557 0.66 NAMPT (0.52) PIK3CAPIK3R1SMN1; SMN2KDM4EALDH1A1
SCHEMBL19553269 0.65 AR (0.42) ARPRKDCSMN1; SMN2KDM4EALDH1A1
SCHEMBL30627541 0.63 PIK3CA (0.59) PIK3CAPIK3R1KDM4EPOLBLMNA
SCHEMBL184869 0.63 GAA (0.53) PIK3CAPIK3R1ARSMN1; SMN2KDM4E
SCHEMBL28418430 0.63 AR (0.41) PIK3CAPIK3R1ARPRKDCSMN1; SMN2
SCHEMBL13271393 0.63 AR (0.41) PIK3CAPIK3R1ARPRKDCSMN1; SMN2
SCHEMBL16002359 0.63 DPP4 (0.41) PIK3CAPIK3R1ARPRKDCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed